146 related articles for article (PubMed ID: 38739656)
1. NYU Clinical Practice Guidelines for VTE ProphylaxisHip and Knee Arthroplasty.
Arshi A; Rozell JC; Aggarwal VK; Schwarzkopf R
Bull Hosp Jt Dis (2013); 2024 Jun; 82(2):103-105. PubMed ID: 38739656
[No Abstract] [Full Text] [Related]
2. The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.
Chu JN; Maselli J; Auerbach AD; Fang MC
Thromb Res; 2017 Jul; 155():65-71. PubMed ID: 28501678
[TBL] [Abstract][Full Text] [Related]
3. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
[TBL] [Abstract][Full Text] [Related]
4. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.
Forster R; Stewart M
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384
[TBL] [Abstract][Full Text] [Related]
6. New anticoagulants for thromboprophylaxis after total knee arthroplasty.
Brown TS; Huo MH
Am J Orthop (Belle Mead NJ); 2013 Sep; 42(9):424-9. PubMed ID: 24078968
[TBL] [Abstract][Full Text] [Related]
7. Venous Thromboembolism Prophylaxis in Total Hip Arthroplasty and Total Knee Arthroplasty Patients: From Guidelines to Practice.
Lieberman JR; Heckmann N
J Am Acad Orthop Surg; 2017 Dec; 25(12):789-798. PubMed ID: 29176502
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolic disease after total hip and knee arthroplasty.
Haas SB; Barrack RL; Westrich G; Lachiewicz PF
J Bone Joint Surg Am; 2008 Dec; 90(12):2764-80. PubMed ID: 19047723
[No Abstract] [Full Text] [Related]
9. Venous thromboembolism after total knee replacement or total hip replacement: what can be learnt from root-cause analysis?
Benjamin S; Warwick D
Ann R Coll Surg Engl; 2016 Nov; 98(8):538-542. PubMed ID: 27513792
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism after total hip arthroplasty and total knee arthroplasty: current and future perspectives.
Merli G
Am J Manag Care; 2011 Feb; 17(1 Suppl):S4-5. PubMed ID: 21548183
[No Abstract] [Full Text] [Related]
11. Comparison of pharmacologic prophylaxis in prevention of venous thromboembolism following total knee arthroplasty.
Richardson SS; Schairer WW; Sculco PK; Bostrom MP
Knee; 2019 Mar; 26(2):451-458. PubMed ID: 30700390
[TBL] [Abstract][Full Text] [Related]
12. Prevention of venous thromboembolism after total joint arthroplasty: aspirin is enough for most patients.
Dalury D; Lonner J; Parvizi J
Am J Orthop (Belle Mead NJ); 2015 Feb; 44(2):59-60. PubMed ID: 25658072
[No Abstract] [Full Text] [Related]
13. The Risk of Venous Thromboembolism is Not Equal for all Patients Who Undergo Total Joint Replacement.
Tafur A; Fareed J
Clin Appl Thromb Hemost; 2019; 25():1076029619838062. PubMed ID: 30939893
[No Abstract] [Full Text] [Related]
14. Venous Thromboembolism Chemoprophylaxis in Total Hip and Knee Arthroplasty: A Critical Analysis Review.
Trivedi NN; Fitzgerald SJ; Schmaier AH; Wera GD
JBJS Rev; 2019 Jan; 7(1):e2. PubMed ID: 30601202
[No Abstract] [Full Text] [Related]
15. Compliance with Australian Orthopaedic Association guidelines does not reduce the risk of venous thromboembolism after total hip and knee arthroplasty.
Badge H; Churches T; Naylor JM; Xuan W; Armstrong E; Gray L; Fletcher J; Gosbell I; Lin CC; Harris IA
Sci Rep; 2024 Mar; 14(1):5955. PubMed ID: 38467650
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and economic burden of venous thromboembolism after total hip arthroplasty or total knee arthroplasty.
Baser O
Am J Manag Care; 2011 Feb; 17(1 Suppl):S6-8. PubMed ID: 21517654
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism after total hip arthroplasty and total knee arthroplasty: current and future perspectives. Epilogue.
Merli G
Am J Manag Care; 2011 Feb; 17(1 Suppl):S33. PubMed ID: 21548181
[No Abstract] [Full Text] [Related]
18. The Role of Intraoperative Intermittent Pneumatic Compression Devices in Venous Thromboembolism Prophylaxis in Total Hip and Total Knee Arthroplasty.
Tyagi V; Tomaszewski P; Lukasiewicz A; Theriault S; Pelker R
Orthopedics; 2018 Jan; 41(1):e98-e103. PubMed ID: 29156069
[TBL] [Abstract][Full Text] [Related]
19. Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.
Levitan B; Yuan Z; Turpie AG; Friedman RJ; Homering M; Berlin JA; Berkowitz SD; Weinstein RB; DiBattiste PM
Vasc Health Risk Manag; 2014; 10():157-67. PubMed ID: 24707185
[TBL] [Abstract][Full Text] [Related]
20. Dabigatran etexilate for prevention of venous thromboembolism.
Eikelboom JE; Weitz JI
Thromb Haemost; 2009 Jan; 101(1):2-4. PubMed ID: 19132179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
